Medical Care

Global Critical Care Therapeutics Market Research Report 2025

The global market for Critical Care Therapeutics was valued at US$ 3061 million in the year 2024 and is projected to reach a revised size of US$ 3576 million by 2031, growing at a CAGR of 2.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Critical Care Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Critical Care Therapeutics.
The Critical Care Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Critical Care Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Critical Care Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CSL Behring
Grifols
Kedrion Biopharma
Octapharma
Takeda
Bayer HealthCare
Merck
Mitsubishi Tanabe Pharma
REVO Biologics
Rockwell Medical
Thermo Fisher Scientific
Shanghai RAAS
China Biologic Products
Cosmo Pharmaceuticals
King Pharmaceuticals
Segment by Type
Albumin
Prothrombin Complex Concentrates
Antithrombin Concentrates
Factor XIII Concentrates
Fibrinogen Concentrates
Segment by Application
Pulmonary Embolism (PE)
Acute Coronary Syndrome
Atrial Fibrillation
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Critical Care Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Critical Care Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Albumin
1.2.3 Prothrombin Complex Concentrates
1.2.4 Antithrombin Concentrates
1.2.5 Factor XIII Concentrates
1.2.6 Fibrinogen Concentrates
1.3 Market by Application
1.3.1 Global Critical Care Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pulmonary Embolism (PE)
1.3.3 Acute Coronary Syndrome
1.3.4 Atrial Fibrillation
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Critical Care Therapeutics Market Perspective (2020-2031)
2.2 Global Critical Care Therapeutics Growth Trends by Region
2.2.1 Global Critical Care Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Critical Care Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Critical Care Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Critical Care Therapeutics Market Dynamics
2.3.1 Critical Care Therapeutics Industry Trends
2.3.2 Critical Care Therapeutics Market Drivers
2.3.3 Critical Care Therapeutics Market Challenges
2.3.4 Critical Care Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Critical Care Therapeutics Players by Revenue
3.1.1 Global Top Critical Care Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Critical Care Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Critical Care Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Critical Care Therapeutics Revenue
3.4 Global Critical Care Therapeutics Market Concentration Ratio
3.4.1 Global Critical Care Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Critical Care Therapeutics Revenue in 2024
3.5 Global Key Players of Critical Care Therapeutics Head office and Area Served
3.6 Global Key Players of Critical Care Therapeutics, Product and Application
3.7 Global Key Players of Critical Care Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Critical Care Therapeutics Breakdown Data by Type
4.1 Global Critical Care Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Critical Care Therapeutics Forecasted Market Size by Type (2026-2031)
5 Critical Care Therapeutics Breakdown Data by Application
5.1 Global Critical Care Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Critical Care Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Critical Care Therapeutics Market Size (2020-2031)
6.2 North America Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Critical Care Therapeutics Market Size by Country (2020-2025)
6.4 North America Critical Care Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Critical Care Therapeutics Market Size (2020-2031)
7.2 Europe Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Critical Care Therapeutics Market Size by Country (2020-2025)
7.4 Europe Critical Care Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Critical Care Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Critical Care Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Critical Care Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Critical Care Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Critical Care Therapeutics Market Size (2020-2031)
9.2 Latin America Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Critical Care Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Critical Care Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Critical Care Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Critical Care Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Critical Care Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Critical Care Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Critical Care Therapeutics Introduction
11.1.4 CSL Behring Revenue in Critical Care Therapeutics Business (2020-2025)
11.1.5 CSL Behring Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Critical Care Therapeutics Introduction
11.2.4 Grifols Revenue in Critical Care Therapeutics Business (2020-2025)
11.2.5 Grifols Recent Development
11.3 Kedrion Biopharma
11.3.1 Kedrion Biopharma Company Details
11.3.2 Kedrion Biopharma Business Overview
11.3.3 Kedrion Biopharma Critical Care Therapeutics Introduction
11.3.4 Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2020-2025)
11.3.5 Kedrion Biopharma Recent Development
11.4 Octapharma
11.4.1 Octapharma Company Details
11.4.2 Octapharma Business Overview
11.4.3 Octapharma Critical Care Therapeutics Introduction
11.4.4 Octapharma Revenue in Critical Care Therapeutics Business (2020-2025)
11.4.5 Octapharma Recent Development
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Critical Care Therapeutics Introduction
11.5.4 Takeda Revenue in Critical Care Therapeutics Business (2020-2025)
11.5.5 Takeda Recent Development
11.6 Bayer HealthCare
11.6.1 Bayer HealthCare Company Details
11.6.2 Bayer HealthCare Business Overview
11.6.3 Bayer HealthCare Critical Care Therapeutics Introduction
11.6.4 Bayer HealthCare Revenue in Critical Care Therapeutics Business (2020-2025)
11.6.5 Bayer HealthCare Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Critical Care Therapeutics Introduction
11.7.4 Merck Revenue in Critical Care Therapeutics Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Mitsubishi Tanabe Pharma
11.8.1 Mitsubishi Tanabe Pharma Company Details
11.8.2 Mitsubishi Tanabe Pharma Business Overview
11.8.3 Mitsubishi Tanabe Pharma Critical Care Therapeutics Introduction
11.8.4 Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2020-2025)
11.8.5 Mitsubishi Tanabe Pharma Recent Development
11.9 REVO Biologics
11.9.1 REVO Biologics Company Details
11.9.2 REVO Biologics Business Overview
11.9.3 REVO Biologics Critical Care Therapeutics Introduction
11.9.4 REVO Biologics Revenue in Critical Care Therapeutics Business (2020-2025)
11.9.5 REVO Biologics Recent Development
11.10 Rockwell Medical
11.10.1 Rockwell Medical Company Details
11.10.2 Rockwell Medical Business Overview
11.10.3 Rockwell Medical Critical Care Therapeutics Introduction
11.10.4 Rockwell Medical Revenue in Critical Care Therapeutics Business (2020-2025)
11.10.5 Rockwell Medical Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Critical Care Therapeutics Introduction
11.11.4 Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 Shanghai RAAS
11.12.1 Shanghai RAAS Company Details
11.12.2 Shanghai RAAS Business Overview
11.12.3 Shanghai RAAS Critical Care Therapeutics Introduction
11.12.4 Shanghai RAAS Revenue in Critical Care Therapeutics Business (2020-2025)
11.12.5 Shanghai RAAS Recent Development
11.13 China Biologic Products
11.13.1 China Biologic Products Company Details
11.13.2 China Biologic Products Business Overview
11.13.3 China Biologic Products Critical Care Therapeutics Introduction
11.13.4 China Biologic Products Revenue in Critical Care Therapeutics Business (2020-2025)
11.13.5 China Biologic Products Recent Development
11.14 Cosmo Pharmaceuticals
11.14.1 Cosmo Pharmaceuticals Company Details
11.14.2 Cosmo Pharmaceuticals Business Overview
11.14.3 Cosmo Pharmaceuticals Critical Care Therapeutics Introduction
11.14.4 Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025)
11.14.5 Cosmo Pharmaceuticals Recent Development
11.15 King Pharmaceuticals
11.15.1 King Pharmaceuticals Company Details
11.15.2 King Pharmaceuticals Business Overview
11.15.3 King Pharmaceuticals Critical Care Therapeutics Introduction
11.15.4 King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025)
11.15.5 King Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Critical Care Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Albumin
Table 3. Key Players of Prothrombin Complex Concentrates
Table 4. Key Players of Antithrombin Concentrates
Table 5. Key Players of Factor XIII Concentrates
Table 6. Key Players of Fibrinogen Concentrates
Table 7. Global Critical Care Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Critical Care Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Critical Care Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Critical Care Therapeutics Market Share by Region (2020-2025)
Table 11. Global Critical Care Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Critical Care Therapeutics Market Share by Region (2026-2031)
Table 13. Critical Care Therapeutics Market Trends
Table 14. Critical Care Therapeutics Market Drivers
Table 15. Critical Care Therapeutics Market Challenges
Table 16. Critical Care Therapeutics Market Restraints
Table 17. Global Critical Care Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Critical Care Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Critical Care Therapeutics as of 2024)
Table 20. Ranking of Global Top Critical Care Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Critical Care Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Critical Care Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Critical Care Therapeutics, Product and Application
Table 24. Global Key Players of Critical Care Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Critical Care Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Critical Care Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Critical Care Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Critical Care Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Critical Care Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Critical Care Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Critical Care Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Critical Care Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Critical Care Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Critical Care Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Critical Care Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Critical Care Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Critical Care Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Critical Care Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. CSL Behring Company Details
Table 50. CSL Behring Business Overview
Table 51. CSL Behring Critical Care Therapeutics Product
Table 52. CSL Behring Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 53. CSL Behring Recent Development
Table 54. Grifols Company Details
Table 55. Grifols Business Overview
Table 56. Grifols Critical Care Therapeutics Product
Table 57. Grifols Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 58. Grifols Recent Development
Table 59. Kedrion Biopharma Company Details
Table 60. Kedrion Biopharma Business Overview
Table 61. Kedrion Biopharma Critical Care Therapeutics Product
Table 62. Kedrion Biopharma Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 63. Kedrion Biopharma Recent Development
Table 64. Octapharma Company Details
Table 65. Octapharma Business Overview
Table 66. Octapharma Critical Care Therapeutics Product
Table 67. Octapharma Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Octapharma Recent Development
Table 69. Takeda Company Details
Table 70. Takeda Business Overview
Table 71. Takeda Critical Care Therapeutics Product
Table 72. Takeda Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Takeda Recent Development
Table 74. Bayer HealthCare Company Details
Table 75. Bayer HealthCare Business Overview
Table 76. Bayer HealthCare Critical Care Therapeutics Product
Table 77. Bayer HealthCare Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 78. Bayer HealthCare Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Critical Care Therapeutics Product
Table 82. Merck Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Mitsubishi Tanabe Pharma Company Details
Table 85. Mitsubishi Tanabe Pharma Business Overview
Table 86. Mitsubishi Tanabe Pharma Critical Care Therapeutics Product
Table 87. Mitsubishi Tanabe Pharma Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 88. Mitsubishi Tanabe Pharma Recent Development
Table 89. REVO Biologics Company Details
Table 90. REVO Biologics Business Overview
Table 91. REVO Biologics Critical Care Therapeutics Product
Table 92. REVO Biologics Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 93. REVO Biologics Recent Development
Table 94. Rockwell Medical Company Details
Table 95. Rockwell Medical Business Overview
Table 96. Rockwell Medical Critical Care Therapeutics Product
Table 97. Rockwell Medical Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 98. Rockwell Medical Recent Development
Table 99. Thermo Fisher Scientific Company Details
Table 100. Thermo Fisher Scientific Business Overview
Table 101. Thermo Fisher Scientific Critical Care Therapeutics Product
Table 102. Thermo Fisher Scientific Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 103. Thermo Fisher Scientific Recent Development
Table 104. Shanghai RAAS Company Details
Table 105. Shanghai RAAS Business Overview
Table 106. Shanghai RAAS Critical Care Therapeutics Product
Table 107. Shanghai RAAS Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 108. Shanghai RAAS Recent Development
Table 109. China Biologic Products Company Details
Table 110. China Biologic Products Business Overview
Table 111. China Biologic Products Critical Care Therapeutics Product
Table 112. China Biologic Products Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 113. China Biologic Products Recent Development
Table 114. Cosmo Pharmaceuticals Company Details
Table 115. Cosmo Pharmaceuticals Business Overview
Table 116. Cosmo Pharmaceuticals Critical Care Therapeutics Product
Table 117. Cosmo Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 118. Cosmo Pharmaceuticals Recent Development
Table 119. King Pharmaceuticals Company Details
Table 120. King Pharmaceuticals Business Overview
Table 121. King Pharmaceuticals Critical Care Therapeutics Product
Table 122. King Pharmaceuticals Revenue in Critical Care Therapeutics Business (2020-2025) & (US$ Million)
Table 123. King Pharmaceuticals Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report


List of Figures
Figure 1. Critical Care Therapeutics Picture
Figure 2. Global Critical Care Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Critical Care Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Albumin Features
Figure 5. Prothrombin Complex Concentrates Features
Figure 6. Antithrombin Concentrates Features
Figure 7. Factor XIII Concentrates Features
Figure 8. Fibrinogen Concentrates Features
Figure 9. Global Critical Care Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Critical Care Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Pulmonary Embolism (PE) Case Studies
Figure 12. Acute Coronary Syndrome Case Studies
Figure 13. Atrial Fibrillation Case Studies
Figure 14. Other Case Studies
Figure 15. Critical Care Therapeutics Report Years Considered
Figure 16. Global Critical Care Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Critical Care Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Critical Care Therapeutics Market Share by Region: 2024 VS 2031
Figure 19. Global Critical Care Therapeutics Market Share by Players in 2024
Figure 20. Global Top Critical Care Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Critical Care Therapeutics as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Critical Care Therapeutics Revenue in 2024
Figure 22. North America Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Critical Care Therapeutics Market Share by Country (2020-2031)
Figure 24. United States Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Critical Care Therapeutics Market Share by Country (2020-2031)
Figure 28. Germany Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Critical Care Therapeutics Market Share by Region (2020-2031)
Figure 36. China Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Critical Care Therapeutics Market Share by Country (2020-2031)
Figure 44. Mexico Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Critical Care Therapeutics Market Share by Country (2020-2031)
Figure 48. Turkey Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Critical Care Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. CSL Behring Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 52. Grifols Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 53. Kedrion Biopharma Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 54. Octapharma Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 55. Takeda Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 56. Bayer HealthCare Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 57. Merck Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 58. Mitsubishi Tanabe Pharma Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 59. REVO Biologics Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 60. Rockwell Medical Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 62. Shanghai RAAS Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 63. China Biologic Products Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 64. Cosmo Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 65. King Pharmaceuticals Revenue Growth Rate in Critical Care Therapeutics Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies